Tetrahedron Letters
An unexpected route for the synthesis of a new spiroheterocyclic
system from ninhydrin
Yovanny Quevedo-Acosta a, Adrián Pérez-Redondo b, Rodolfo Quevedo a,
⇑
a Universidad Nacional de Colombia, Sede Bogotá, Facultad de Ciencias, Departamento de Química, Carrera 30 No. 45-03, Bogotá, Colombia
b Departamento de Química Orgánica y Química Inorgánica, Universidad de Alcalá, 28871 Alcalá de Henares-Madrid, Spain
a r t i c l e i n f o
a b s t r a c t
Article history:
The reaction of ninhydrin with amines leads to the formation of Ruhemann’s purple. This study presents
the synthesis of Ruhemann’s purple and a new benzo-fused spiroheterocyclic system by the reaction
between ninhydrin and phenylethylamine. The structure was established using spectroscopic data and
X-ray crystal structure analysis.
Received 17 July 2015
Revised 28 July 2015
Accepted 29 July 2015
Available online xxxx
Ó 2015 Elsevier Ltd. All rights reserved.
Keywords:
Ninhydrin
Phenylethylamine
Pictet–Spengler
Phenylacetaldehyde
Ruhemann’s purple
We have observed that the hydroxylation degree on the aro-
matic ring influences the reactivity of b-phenylethylamines to
non-enolizable aldehydes. The product obtained depends on the
hydroxylation degree of the original phenylethylamine ring.
When the reaction is performed between dopamine and formalde-
hyde, the corresponding 1,2,3,4-tetrahydroisoquinoline is obtained
by a Pictet–Spengler reaction; when the reaction is performed
between tyramine and formaldehyde, an azacyclophane is obtained
by a double aromatic Mannich reaction; and when the reaction is
performed between phenylethylamine and formaldehyde, a triple
amine–aldehyde condensation leads to the corresponding hexahy-
dro-1,3,5-triphenyl-1,3,5-triazine.1–3
On the other hand, ninhydrin 1 is a highly electrophilic
tricarbonyl compound derived from indane. The electrophilic
character is high due to the presence of three consecutive
electron-withdrawing groups, the most electrophilic of which is
carbon 2. The presence of three electrophilic groups makes it very
interesting from a chemical perspective, and it has been the object
of many studies aimed at obtaining heterocyclic compounds with
great structural diversity.4
form an aldehyde and Ruhemann’s purple 2 by interaction with a
second molecule of ninhydrin (Scheme 1).9
Recent studies showed that dopamine
3 (3,4-dihydroxy-
phenethylamine) does not form the expected Ruhemann’s purple
2 and, when reacting with ninhydrin, produces a mixture of
spiro-tetrahydroisoquinoline-type 4 regioisomers by a Pictet–
Spengler condensation (Scheme 2).10
We here extend our studies on the reactivity of phenylethy-
lamines and describe the reaction of b-phenylethylamine with
ninhydrin as a synthetic method to produce a new benzo-fused
spiroheterocyclic system. The synthesis described involves a tri-
component condensation between phenylacetaldehyde generated
in situ, phenylethylamine, and ninhydrin.
Our studies show that phenylethylamine 5 exposed to ninhy-
drin 1 does not present the usual behavior described for amines
and, along with Ruhemann’s purple 2, predominantly produces a
compound that is violet in solution form and colorless in the solid
state 6.11 The analysis of 1H NMR and 13C NMR spectra showed a
greater number of signals than those expected for the Schiff base
or the corresponding tetrahydroisoquinoline. The additional
signals indicate the presence of a third aromatic unit with two
aliphatic carbons, most likely from a phenylacetaldehyde molecule
formed in situ.
The reaction of ninhydrin 1 with amines usually leads to a sin-
gle product known as Ruhemann’s purple 2; as a result, it is used in
a variety of analytical techniques.5–9 This reaction starts with the
formation of a Schiff base, which tautomerizes and hydrolyzes to
The structure of the new compound was determined by IR spec-
troscopic analysis, NMR (1H, 13C, COSY, HMQC and HMBC) and
mass spectrometry (EI-MS and ESI-MS). In the HMBC experiment,
we obtained key data that assisted in determining the structure,
⇑
Corresponding author. Fax: +57 1 316 5220.
0040-4039/Ó 2015 Elsevier Ltd. All rights reserved.